EYRC (@enea_young) 's Twitter Profile
EYRC

@enea_young

The ENEA Young Researchers Committee (EYRC) is a subcommittee of the European Neuroendocrine Association (ENEA)

ID: 3997216456

linkhttps://eneassoc.org/?page_id=5181 calendar_today19-10-2015 21:04:25

1,1K Tweet

1,1K Followers

1,1K Following

EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿš€ Excited to Launch โ€œEYRC Interview - Career in Progress,โ€ where we spotlight mid-career researchers shaping the field of neuroendocrinology ๐ŸŒŸ First up: Dr. Nicole Bechmann, a leader in adrenal gland tumor research! Link to the full interview: youtube.com/watch?v=QsCaM5โ€ฆ

EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿš€ Exciting News! The EYRC Podcast is LIVE! The EYRC is launching a brand-new podcast covering the latest expert interviews! ๐Ÿ“Œ EYRC Podcast Hub: enea.org/category/eyrc-โ€ฆ ๐Ÿ Apple Podcasts: podcasts.apple.com/fr/podcast/eneโ€ฆ

๐Ÿš€ Exciting News! The EYRC Podcast is LIVE! 

The EYRC is launching a brand-new podcast covering the latest expert interviews! 

๐Ÿ“Œ EYRC Podcast Hub: enea.org/category/eyrc-โ€ฆ
๐Ÿ Apple Podcasts: podcasts.apple.com/fr/podcast/eneโ€ฆ
EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿง  New EYRC Neuroendocrinology Watch! Ravel et al. show additive effects of ALXN2420 (GH receptor antagonist) + octreotide on IGF1 suppression in vivo. Exciting data for acromegaly treatment! ๐Ÿ”— More insights on LinkedIn: linkedin.com/feed/update/urโ€ฆ

๐Ÿง  New EYRC Neuroendocrinology Watch!

Ravel et al. show additive effects of ALXN2420 (GH receptor antagonist) + octreotide on IGF1 suppression in vivo.
Exciting data for acromegaly treatment!
๐Ÿ”— More insights on LinkedIn:
linkedin.com/feed/update/urโ€ฆ
EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿ’กApril 8 is Cushingโ€™s Disease Awareness Day ๐Ÿ’ก A rare but serious condition often missed or misdiagnosed. Early diagnosis can change lives. #CushingsAwareness #RareDiseases

๐Ÿ’กApril 8 is Cushingโ€™s Disease Awareness Day ๐Ÿ’ก

A rare but serious condition often missed or misdiagnosed.

Early diagnosis can change lives.

#CushingsAwareness #RareDiseases
EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿง  New EYRC Neuroendocrinology Watch! Cabozantinib significantly prolongs PFS in patients with pancreatic & extrapancreatic NETs. ๐Ÿ“Š Phase 3, placebo-controlled, multicenter study ๐Ÿ”— More insights on LinkedIn: linkedin.com/company/enea-yโ€ฆ

๐Ÿง  New EYRC Neuroendocrinology Watch!

Cabozantinib significantly prolongs PFS in patients with pancreatic & extrapancreatic NETs.

๐Ÿ“Š Phase 3, placebo-controlled, multicenter study
๐Ÿ”— More insights on LinkedIn: linkedin.com/company/enea-yโ€ฆ
EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿšจ New Neuroendo Watch by EYRC โ€“ Highlight Alert! We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. ๐Ÿงช Full post with takeaways on our LinkedIn page: linkedin.com/company/enea-yโ€ฆ

๐Ÿšจ New Neuroendo Watch by EYRC โ€“ Highlight Alert! 

 We spotlight a study revealing how cholesterol metabolism drives dopamine agonist resistance in prolactinomas. ๐Ÿงช

 Full post with takeaways on our LinkedIn page: linkedin.com/company/enea-yโ€ฆ
EYRC (@enea_young) 's Twitter Profile Photo

๐ŸŽฅ Just out! Dr. Pedro Marques interviewed Prof. Anton Luger at the 2025 Portuguese Endocrinology Congress ๐Ÿ‡ต๐Ÿ‡นโœจ Watch the full interview on LinkedIn: linkedin.com/company/enea-yโ€ฆ and YouTube via EYRC: youtu.be/C8xxIGnydrk

EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿ•’ Can restoring cortisol rhythms improve outcomes in Cushing's Syndrome? A new study suggests once-daily osilodrostat may enhance sleep & QoL via chronotherapy! ๐ŸŒ™ ๐Ÿ‘‰ Full breakdown on our LinkedIn page: linkedin.com/company/enea-yโ€ฆ

๐Ÿ•’ Can restoring cortisol rhythms improve outcomes in Cushing's Syndrome?

A new study suggests once-daily osilodrostat may enhance sleep & QoL via chronotherapy! ๐ŸŒ™

๐Ÿ‘‰ Full breakdown on our LinkedIn page: linkedin.com/company/enea-yโ€ฆ
EYRC (@enea_young) 's Twitter Profile Photo

๐Ÿšจ New Neuroendo Watch by EYRC โ€“ Highlight Alert! We spotlight a study that investigates how acromegaly alters the innate immune system independently of glucose metabolism. ๐Ÿ“ทFull post with takeaways on our LinkedIn page: linkedin.com/company/enea-yโ€ฆ

๐Ÿšจ New Neuroendo Watch by EYRC โ€“ Highlight Alert!  

We spotlight a study that investigates how acromegaly alters the innate immune system independently of glucose metabolism.

๐Ÿ“ทFull post with takeaways on our LinkedIn page: linkedin.com/company/enea-yโ€ฆ